The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAthelney Tst. Regulatory News (ATY)

Share Price Information for Athelney Tst. (ATY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 177.50
Bid: 165.00
Ask: 190.00
Change: 0.00 (0.00%)
Spread: 25.00 (15.152%)
Open: 177.50
High: 177.50
Low: 177.50
Prev. Close: 177.50
ATY Live PriceLast checked at -
Athelney is an Investment Trust

To provide shareholders with prospects of long term capital growth by investing in companies with either a full listing on the London Stock Exchange or a trading facility on AIM or ISDX.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Net Asset Value(s)

2 Oct 2020 11:05

RNS Number : 9636A
Athelney Trust PLC
02 October 2020
 

Athelney Trust PLC

 

Legal Entity Identifier:

213800ON67TJC7F4DL05

The unaudited net asset value of Athelney Trust was 230.2p at 30 September 2020.

Fund Manager's comment for September 2020

While the UK PMIs have continued to firm in recent months, the August manufacturing PMI reflected the strongest reading since early 2018 while the services PMI reading was the highest since 2015. However, in an economy responding to targeted stimuli by the Government, this can be misleading and masks underlying structural issues and competitive pressures on the profitability of some businesses. In fact, the gains in the PMI surveys have not been matched by a similar strength in hard activity data, such as GDP, retail sales and industrial output, prompting the Bank of England (BoE) to hold its Bank Rate at 0.1% and its asset purchase target unchanged at £745B.

During the past month global stock markets were under pressure with the MSCI World Index and the S&P 500 down (in US$) by 3.6% and 3.9% respectively, largely driven by the decline in the large technology stocks from their highs in August. The 3.5% decline in the pound resulted in the UK market under-performing the global indices in US$. The FTSE 100 was down by 0.1% as was the AIM All Share Index, the FTSE 250 was down by 2%, the Small Cap Index declined by 1.4%, while the Fledgling Index was up by 1% for the month.

While our overall performance was once again dragged down by our 29% exposure to the property trusts, we are nevertheless pleased with the overall result with the portfolio declining by 1.1% during the month. After providing for the interim dividend and company expenses the net performance as reflected in the NAV was a decline of 2.2%.

Until the direction of the Brexit negotiations and the potential success of a Covid-19 vaccine is a little clearer we have chosen to do very little, using some of our cash to acquire additional shares in Smart Metering and Churchill China and to pay the interim dividend. Cash comprised 2.6% of the portfolio at month end.

 

Fact Sheet

An accompanying fact sheet which includes the information above as well as wider details on the portfolio can be found on the Fund's website www.athelneytrust.co.uk under "Portfolio Details".

Background Information

Dr. Emmanuel (Manny) Pohl AM

Manny is Chairman and Chief Investment Officer of E C Pohl & Co ("ECP"), an investment management company and has been a major shareholder in Athelney trust for many years.

E C Pohl & co is licensed by the Australian Financial services (licence no.421704).

www.ecpohl.com

www.ecpam.com

Manny Pohl and the ECP group has over AU$1500m under its management including four listed investment companies, three listed in Australia and one in the UK:

· Flagship Investments (ASX code:FSI)

AUD50m https://flagshipinvestments.com.au

· Barrack St Investments (ASX code: BST)

AUD25m www.barrackst.com

· Global Masters Fund Limited (ASX code: GFL)

AUD25m www.globalmastersfund.com.au

· Athelney Trust plc (LSE code: ATY)

GBP5m www.athelneytrust.co.uk

Athelney Trust plc Investment Policy

 The investment objective of the Trust is to provide shareholders with prospects of long-term capital growth with the risks inherent in small cap investment minimised through a spread of holdings in quality small cap companies that operate in various industries and sectors. The Fund Manager also considers that it is important to maintain a progressive dividend record.

The assets of the Trust are allocated predominantly to companies with either a full listing on the London Stock Exchange or a trading facility on AIM or ISDX. The assets of the Trust have been allocated in two main ways: first, to the shares of those companies which have grown steadily over the years in terms of profits and dividends but, despite this progress, the market rating is favourable when compared to future earnings and dividends; second, to those companies whose shares are standing at a favourable level compared with the value of land, buildings or cash in the balance sheet.

Athelney Trust was founded in 1994. In 1996 it was one of the ten pioneer members of the Alternative Investment Market ("AIM"). In 2008 the shares became fully listed on the main market of the London Stock Exchange. Athelney Trust has a successful progressive dividend growth record and the dividend has grown every year since 2004. According to the Association of Investment Companies (AIC) Athelney Trust is one of only "22 investment companies that have increased their dividend every year between 10 and 20 years - the next generation of dividend heroes" (as at 20/03/2018). See link

www.theaic.co.uk/aic/news/press-releases/next-generation-of-dividend-heroes

Website

www.athelneytrust.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVBGBDGUGGDGGD
Date   Source Headline
6th Mar 20157:00 amRNSFinal Results
2nd Mar 20153:42 pmRNSNet Asset Value(s)
3rd Feb 20152:18 pmRNSNet Asset Value(s)
30th Jan 20151:05 pmRNSDirectorate Change
6th Jan 20159:59 amRNSNet Asset Value(s)
29th Dec 201410:21 amRNSHolding(s) in Company
29th Dec 201410:20 amRNSDirector/PDMR Shareholding
2nd Dec 201411:06 amRNSNet Asset Value(s)
4th Nov 20149:00 amRNSNet Asset Value(s)
6th Oct 20141:54 pmRNSNet Asset Value(s)
4th Sep 201410:42 amRNSNet Asset Value(s)
21st Aug 20143:13 pmRNSDirectorate Change
18th Aug 20142:11 pmRNSFormal Notice
4th Aug 20142:36 pmRNSNet Asset Value(s)
1st Aug 20147:00 amRNSHalf Yearly Report
3rd Jul 201412:31 pmRNSNet Asset Value(s)
13th Jun 201412:21 pmRNSDirector/PDMR Shareholding
13th Jun 201412:21 pmRNSHolding(s) in Company
4th Jun 20148:57 amRNSNet Asset Value(s)
6th May 20142:22 pmRNSNet Asset Value(s)
11th Apr 20149:25 amRNSAGM Statement
8th Apr 201412:57 pmRNSNet Asset Value(s)
7th Mar 20147:00 amRNSFinal Results
3rd Mar 20142:32 pmRNSNet Asset Value(s)
10th Feb 20149:11 amRNSNet Asset Value(s)
3rd Jan 20142:50 pmRNSNet Asset Value(s)
20th Dec 201312:48 pmRNSHolding(s) in Company
20th Dec 201312:36 pmRNSDirector/PDMR Shareholding
5th Dec 201310:08 amRNSNet Asset Value(s)
7th Nov 201312:16 pmRNSNet Asset Value(s)
8th Oct 20139:44 amRNSNet Asset Value(s)
4th Sep 201311:17 amRNSNet Asset Value(s)
22nd Aug 20133:54 pmRNSDirector/PDMR Shareholding
5th Aug 20134:16 pmRNSDirector/PDMR Shareholding
2nd Aug 20133:09 pmRNSNet Asset Value(s)
2nd Aug 20137:00 amRNSHalf Yearly Report
5th Jul 20139:35 amRNSNet Asset Value(s)
4th Jun 201310:47 amRNSNet Asset Value(s)
20th May 20139:07 amRNSDirector/PDMR Shareholding
2nd May 201311:15 amRNSNet Asset Value(s)
11th Apr 20133:20 pmRNSAGM Statement
9th Apr 20131:15 pmRNSNet Asset Value(s)
8th Mar 201312:03 pmRNSCorrection
8th Mar 20137:00 amRNSFinal Results
4th Mar 201310:23 amRNSNet Asset Value(s)
5th Feb 20139:36 amRNSNet Asset Value(s)
7th Jan 201312:08 pmRNSNet Asset Value(s)
7th Dec 20123:28 pmRNSNet Asset Value(s)
6th Nov 20129:13 amRNSNet Asset Value(s)
4th Oct 201211:59 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.